Group 1: Market Overview - The A-share market experienced a slight decline on May 28, with major indices showing minor drops, including the Shanghai Composite Index down 0.02% and the Shenzhen Component down 0.26% [4] - The food and beverage sector performed well, with a rise of over 1.5%, highlighted by stocks like Huanlejia and Xinruye reaching their daily limit [4][5] Group 2: BYD's Stock Performance - BYD's A-shares and H-shares both fell over 2%, with H-shares experiencing a drop of more than 3%, marking three consecutive days of decline [3][15] - The decline was attributed to rumors regarding financial issues faced by a BYD dealer group in Shandong, which the company later refuted, stating that the information was untrue [15] - BYD is actively supporting the dealer group and has launched significant promotional activities, offering discounts of up to 53,000 yuan on various models [15][16] Group 3: Individual Stock Movements - Several high-profile stocks experienced significant fluctuations, with some, like Zhongyida, dropping by 7.63% and hitting the limit down [8][12] - Conversely, stocks such as Huijishan and Yunnei Power saw consecutive daily limit increases, indicating strong market interest [12][14] Group 4: Hong Kong Market Dynamics - The Hong Kong market also faced declines, with the Hang Seng Index down 0.53% and the Hang Seng Tech Index down 0.15% [17][18] - Notably, stocks like Yaoshi Bang surged by 13.18% following a share buyback announcement, reflecting confidence in the company's long-term growth prospects [20]

Market Overview - The A-share market indices experienced a decline on May 28, with the Shanghai Composite Index down by 0.02%, Shenzhen Component down by 0.26%, ChiNext down by 0.31%, and the Science and Technology Innovation 50 Index down by 0.23% [5][4]. - The food and beverage sector performed well, leading the market with a gain of over 1.5%, highlighted by stocks such as Huanlejia and Xinruye reaching their daily limit up [5][6]. Individual Stock Performance - There was a notable divergence in individual stock performances, with several popular stocks experiencing significant drops, while others, like Huakai Mountain, achieved consecutive limit-up days [8][13]. - BYD's A-shares and H-shares both fell over 2%, with H-shares dropping more than 3% at one point, attributed to ongoing concerns regarding a dealer's financial issues in Shandong [3][16]. Sector Performance - The warehousing and logistics, textile and apparel, oil, and environmental protection sectors saw gains, while sectors such as paper, chemicals, agriculture, and software services faced declines [7]. - The gold concept stocks showed strong performance, with leading stocks like Laofengxiang hitting the daily limit up, despite a slight adjustment in gold prices [7]. Notable Stock Movements - Individual stocks like Zhongyida and Yibin Paper experienced significant declines, with Zhongyida dropping 7.63% and Yibin Paper hitting the daily limit down [9][11]. - The CXO concept stocks faced downward pressure, with stocks like Ruizhi Pharmaceutical dropping 6.80% [7]. BYD's Response to Dealer Issues - BYD addressed rumors regarding financial troubles of a dealer group, clarifying that the issues stemmed from rapid expansion and leverage, and that they are providing support to the dealer group [16][15]. - The company launched a significant promotional campaign, offering discounts on various models, with some discounts reaching up to 53,000 yuan [17].

Summary of Key Points Core Viewpoint - As of May 28, a total of 65 stocks reached their 52-week highs, with notable performances from Kingway Medical Holdings (08559), China Silver Technology (00515), and Honghui Group (00183) leading the list with high rates of increase [1]. Group 1: Stocks Reaching 52-Week Highs - Kingway Medical Holdings (08559) achieved a closing price of 0.027 with a peak of 0.045, marking a high rate of 32.35% [1]. - China Silver Technology (00515) closed at 0.280, reaching a maximum of 0.305, resulting in a high rate of 28.15% [1]. - Honghui Group (00183) had a closing price of 0.255, with a peak price of 0.255, reflecting a high rate of 27.50% [1]. - Other notable stocks include Emperor Watch and Jewellery (00887) with a high rate of 27.14% and Sogo Department Store (00312) at 21.79% [1]. Group 2: Additional Stocks with Significant Increases - Lehua Entertainment (02306) reached a high rate of 13.73% with a closing price of 2.540 [1]. - Kingway Medical (08143) had a closing price of 0.124 and a peak of 0.230, resulting in a high rate of 10.05% [1]. - Other stocks with notable increases include Zhu Feng Gold (01815) at 6.98% and Yaoshi Bang (09885) at 6.68% [1]. Group 3: Stocks with Lower Performance - The report also includes stocks that did not perform as well, with some reaching their 52-week lows, such as China Parenting Network (01736) with a low rate of -14.40% [2]. - XI Nan Tes-U (09366) and XI Nan Tes (07366) also showed declines of -10.08% and -8.60% respectively [2]. - Other stocks like He Fu Hui Huang (00733) and Pai Ge Biomedical-B (02565) experienced decreases of -7.04% and -6.95% [2].

Market Overview - The Hong Kong stock market opened high but closed lower, with the Hang Seng Index down 0.53% to 23,258.31 points and a total trading volume of 180.82 billion HKD [1] - Citic Securities anticipates a volatile upward trend for Hong Kong stocks in Q3, with potential performance upgrades in Q4 due to domestic growth policies and AI industry catalysts [1] Blue-Chip Stocks Performance - Kuaishou-W (01024) rose 5.95% to 51.65 HKD after reporting Q1 revenue of 32.608 billion RMB, a 10.9% YoY increase, and an adjusted net profit of 4.58 billion RMB, up 4.4% YoY [2] - Other blue-chip stocks like Budweiser APAC (01876) and Nongfu Spring (09633) also saw gains, while SMIC (00981) and Li Auto-W (02015) faced declines [2] Sector Performance - Consumer stocks generally rose, with notable gains in beer, dairy, and restaurant sectors, while gaming stocks benefited from increased Macau gaming revenue [3] - Airlines continued to rise, with China Eastern Airlines (00670) up 3.4% as domestic and international flight bookings increased significantly [4] - Nuclear power stocks experienced volatility, with a notable rise in the morning followed by a decline, influenced by U.S. nuclear energy policy announcements [5] Automotive Sector - The automotive sector faced pressure, with several companies like Li Auto-W (02015) declining due to renewed price wars [6] - Analysts suggest that without regulatory intervention, competition will intensify, particularly affecting mid-tier companies [6] Notable Stocks Movements - Yaoshi Bang (09885) reached a new high, up 13.18% after announcing a share buyback plan and reporting significant growth in its proprietary brand business [7] - Alibaba Pictures (01060) rose 11.54% following a strategic shift towards cautious film investment and a focus on its DaMai business [8] - Meizhong Jiahe (02453) surged 10.2% after launching a new language model for proton therapy, showcasing its treatment effectiveness [9] - SF Express (09699) increased by 9.5%, with analysts highlighting its leading position in the third-party delivery market and growth potential [10]

截至2025年5月28日 09:56，恒生医疗保健指数(HSHCI)下跌0.57%。成分股方面涨跌互现，美中嘉和(02453)领涨12.34%，药师帮(09885)上涨3.20%，讯飞医 疗科技(02506)上涨2.92%；一脉阳光(02522)领跌3.50%，科伦博泰生物-B(06990)下跌3.40%，药明合联(02268)下跌2.84%。恒生医疗ETF(513060)下跌 0.40%，最新报价0.5元。流动性方面，恒生医疗ETF盘中换手2.3%，成交2.06亿元。拉长时间看，截至5月27日，恒生医疗ETF近1周日均成交13.29亿元，居 可比基金第一。 2025年5月30日至6月3日，美国临床肿瘤学会（ASCO）年会将在美国芝加哥及线上同步举行。作为全球规模最大的临床肿瘤学会议之一，ASCO年会是众多 生物医药公司发布最新临床研究成果的重要平台，大会已正式公布会议摘要。 跟踪精度方面，截至2025年5月27日，恒生医疗ETF近1月跟踪误差为0.024%，在可比基金中跟踪精度最高。 从估值层面来看，恒生医疗ETF跟踪的恒生医疗保健指数最新市盈率（PE-TTM）仅24.68倍，处于近1年11.68%的分位， ...

Core Viewpoint - The company, Yaoshi Bang, has successfully transitioned to profitability in 2024, showcasing strong growth and operational efficiency despite industry challenges [3][8]. Group 1: Business Performance - In 2024, Yaoshi Bang reported annual revenue of 17.904 billion yuan, a year-on-year increase of 5.5%, and an adjusted net profit of 157 million yuan, up 20% [3]. - The company's stock price has increased by over 68% year-to-date, reflecting a strong rebound in the Hong Kong pharmaceutical sector [3]. - The company has achieved a significant turnaround, with net profit reaching 30.01 million yuan, marking its first full-year profitability [3][8]. Group 2: Operational Efficiency - Yaoshi Bang has improved its operational efficiency, with accounts receivable turnover days decreasing from 3.9 days in 2021 to 1.3 days in 2024, and inventory turnover at 33.4 days [4]. - The company reported operating cash flow inflows of 98.2 million yuan in 2022, 451 million yuan in 2023, and 656 million yuan in 2024, indicating strong cash management [4]. - By the end of 2024, the company had 3.375 billion yuan in cash and cash equivalents, a year-on-year increase of 13.5% [4]. Group 3: Strategic Partnerships and Growth - The company has successfully launched its own brand and strategic partnerships, with self-owned brand transactions reaching 560 million yuan, a year-on-year increase of 532.3% [6]. - Yaoshi Bang's collaboration with key suppliers has enhanced market coverage and sales efficiency, contributing to its growth strategy [6]. - The company has established a comprehensive business model covering the outpatient pharmaceutical industry, with revenue growing from 3.252 billion yuan in 2019 to 17.904 billion yuan in 2024, reflecting a CAGR of 40.66% [8]. Group 4: Market Outlook and Confidence - The company announced a share buyback plan worth 100 million yuan, reflecting management's confidence in future performance [7]. - The chairman emphasized the commitment to digital transformation in the pharmaceutical supply chain, with expectations for significant market growth in the outpatient pharmaceutical sector [7]. - Analysts predict that the outpatient pharmaceutical market in China could exceed 1 trillion yuan by 2027, with digital pharmaceutical distribution reaching 358.3 billion yuan [7].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部分內容所產生或因依賴該等內容而引致的任何損失承擔任何責 任。 YSB Inc. 藥師幫股份有限公司 （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：9885） 自願性公告 股份回購 此公告乃藥師幫股份有限公司（「本公司」）自願向本公司股東（「股 東」）及本公司 潛 在 投 資 者 作 出。 茲提述本公司日期為2025年5月7日、2025年5月9日、2025年5月12日、2025年5月 13日、2025年5月14日、2025年5月15日、2025年5月16日、2025年5月19日、2025年5 月21日、2025年5月22日、2025年5月23日 及2025年5月26日的公告（「該等公告」）， 內容有關（其 中 包 括）其 股 份 回 購 計 劃。本 公 司 將 根 據 市 況 及 資 金 安 排，於 市 場 上回購總額最多1億 港 元 的 股 份。除 另 有 說 明 者 外，本 ...

| 第一章節 | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | | 是 | | | | 證券代號 (如上市) | 09885 | 說明 | | | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | | 庫存股份變動 | | | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | | 庫存股份數目 | 每股發行/出售價 (註4) | | 已發行股份總數 | | | 於下列日期開始時的結存(註1) | 2025年5月26日 | | 681,949,995 | | | 0 | | | | 681,949,995 | | 1). 其他 (請註明) | | | | | % | | | | | | | ...

表格類別： 股票 狀態： 新提交 公司名稱： 藥師幫股份有限公司 (於開曼群島註冊成立之有限公司) 呈交日期： 2025年5月26日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 09885 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部分內容所產生或因依賴該等內容而引致的任何損失承擔任何責 任。 此公告乃藥師幫股份有限公司（「本公司」）自願向本公司股東（「股 東」）及本公司 潛 在 投 資 者 作 出。 茲提述本公司日期為2025年5月7日、2025年5月9日、2025年5月12日、2025年5月 13日、2025年5月14日、2025年5月15日、2025年5月16日、2025年5月19日、2025年 5月21日、2025年5月22日 及2025年5月23日的公告（「該等公告」），內 容 有 關（其 中 包 括）其 股 份 回 購 計 劃。本 公 司 將 根 據 市 況 及 資 金 安 排，於 市 場 上 回 購 總 額 最 多1億 港 元 的 股 份。除 另 有 說 明 者 外，本 公 告 所 用 詞 彙 與 該 等 公 告 所 界 定 者 具 相 同 涵 義。 董 事 會 進 一 步 宣 佈，於2025年5月26日，本 公 司 根 據 ...